Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The classification of placenta praevia – time for a change?

Autor: Oppenheimer, Lawrence W, Farine, Dan, Ritchie, JW Knox

Publikováno v: Fetal & Maternal Medicine Review; Jul1992, Vol. 4 Issue 2, p73-78, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.

Autor: Rampling R; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Peoples S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, Edinburgh, United Kingdom., Mulholland PJ; Department of Oncology, University College London Hospitals, London, United Kingdom., James A; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Al-Salihi O; Adult Neuro-Oncology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom., Twelves CJ; Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, United Kingdom., McBain C; The Christie NHS Foundation Trust, Withington, Manchester, United Kingdom., Jefferies S; Cambridge Cancer Trials Centre, Oncology Clinical Trials, Addensbrooke's Hospital, Cambridge, United Kingdom., Jackson A; Wolfson Molecular Imaging Centre, University of Manchester, Manchester, United Kingdom., Stewart W; Department of Neuropathology, The Queen Elizabeth University Hospital, Glasgow, United Kingdom., Lindner J; Immatics Biotechnologies GmbH, Tübingen, Germany., Kutscher S; Immatics Biotechnologies GmbH, Tübingen, Germany., Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany., McGuigan L; Cancer Research UK Centre for Drug Development, London, United Kingdom., Peters J; Cancer Research UK Centre for Drug Development, London, United Kingdom., Hill K; Cancer Research UK Centre for Drug Development, London, United Kingdom., Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany., Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany., Halford SE; Cancer Research UK Centre for Drug Development, London, United Kingdom., Ritchie JW; Cancer Research UK Centre for Drug Development, London, United Kingdom. james.ritchie@cancer.org.uk.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Oct 01; Vol. 22 (19), pp. 4776-4785. Date of Electronic Publication: 2016 May 25.

Cancer Research UK Centre for Drug Development: translating 21st-century science into the cancer medicines of tomorrow.

Autor: Ritchie JW; Centre for Drug Development, Cancer Research UK, Angel Building, 407 St John Street, London EC1V 4AD, UK. Electronic address: james.ritchie@cancer.org.uk., Williams RJ; Centre for Drug Development, Cancer Research UK, Angel Building, 407 St John Street, London EC1V 4AD, UK.

Publikováno v: Drug discovery today [Drug Discov Today] 2015 Aug; Vol. 20 (8), pp. 995-1003. Date of Electronic Publication: 2015 Mar 17.